Evidence map›Paper›PMID 25278933›Full record

ReviewFrontiers in microbiology2014

Insights into novel antimicrobial compounds and antibiotic resistance genes from soil metagenomes.

Alinne P de Castro, Gabriel da R Fernandes, Octávio L Franco

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in microbiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Microbial Genomics: Innovative Targets and Mechanisms.Antibiotics (Basel, Switzerland) · 2023
    Review
  6. CuZn and ZnO Nanoflowers as Nano-Fungicides againstMaterials (Basel, Switzerland) · 2021
    Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Alinne P de CastroPrograma de Pós-Graduação em Biotecnologia, Universidade Católica Dom Bosco Laboratórios Inova, Campo Grande, Brazil.
Gabriel da R FernandesPrograma de Pós-Graduação em Ciências Genômicas e Biotecnologia, Centro de Analises Proteomicas e Bioquimicas, Universidade Católica de Brasília Brasilia, Brazil.
Octávio L FrancoPrograma de Pós-Graduação em Biotecnologia, Universidade Católica Dom Bosco Laboratórios Inova, Campo Grande, Brazil ; Programa de Pós-Graduação em Ciências Genômicas e Biotecnologia, Centro de Analises Proteomicas e Bioquimicas, Universidade Católica de Brasília Brasilia, Brazil.
Universidade Católica de Brasília · BRUniversidade Católica Dom Bosco · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In recent years a major worldwide problem has arisen with regard to infectious diseases caused by resistant bacteria. Resistant pathogens are related to high mortality and also to enormous healthcare costs. In this field, cultured microorganisms have been commonly focused in attempts to isolate antibiotic resistance genes or to identify antimicrobial compounds. Although this strategy has been successful in many cases, most of the microbial diversity and related antimicrobial molecules have been completely lost. As an alternative, metagenomics has been used as a reliable approach to reveal the prospective reservoir of antimicrobial compounds and antibiotic resistance genes in the uncultured microbial community that inhabits a number of environments. In this context, this review will focus on resistance genes as well as on novel antibiotics revealed by a metagenomics approach from the soil environment. Biotechnology prospects are also discussed, opening new frontiers for antibiotic development.

Indexed as

antibioticsdrug developmentmetagenomeresistance genessoil

Identifiers

PMID25278933
PMCPMC4166954
OpenAlexW2158752832

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.